Ayurcann HoldingsAYURF Days Payable is 52.40 as of Sep. 2025, which is 20% below its 10-year median of 65.28. The stock has 2 warning signs investors should review. Among 919 Drug Manufacturers companies, Ayurcann Holdings ranks better than 64.85% on this metric.
The historical rank and industry rank for Ayurcann Holdings's Days Payable or its related term are showing as below:
AYURF'
s Days Payable Range Over the Past 10 Years
Min: 48.62 Med: 65.28 Max: 120.9
Current: 118.02
During the past 13 years, Ayurcann Holdings's highest Days Payable was 120.90. The lowest was 48.62. And the median was 65.28.
AYURF's Days Payable is ranked better than 64.85% of 919
companies
in the Drug Manufacturers industry
Industry Median: 90.69
vs AYURF: 118.02
Ayurcann Holdings's Days Payable
declined
from Sep. 2024 (159.77) to Sep. 2025 (52.40).
It may suggest that Ayurcann Holdingsaccelerated paying its suppliers.
Ayurcann Holdings Days Payable Related Terms
Ayurcann Holdings Days Payable Historical Data
* Premium members only.
The historical data trend for Ayurcann Holdings's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AYURF vs BSPK, SKYI, CPMD: Days Payable Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Ayurcann Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ayurcann Holdings Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ayurcann Holdings's Days Payable distribution charts can be found below:
* The bar in red indicates where Ayurcann Holdings's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Ayurcann Holdings's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ayurcann Holdings (AYURF) has a Days Payable of 52.40 as of Sep. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Ayurcann Holdings and its competitors. This is 20% below median its historical median of 65.28. Over the past decade, Ayurcann Holdings' Days Payable has ranged from 48.62 to 120.90. According to the industry distribution chart, Ayurcann Holdings ranks #323 out of 919 companies in the Drug Manufacturers industry, placing it in the top 35.1%.
Is Ayurcann Holdings' Days Payable too high?
Ayurcann Holdings' current Days Payable of 52.40 is 20% below median its 10-year median of 65.28. Over the past 10 years, this metric has ranged from a low of 48.62 to a high of 120.90. The Drug Manufacturers industry median Days Payable is 90.69. Ayurcann Holdings' value of 52.40 is 42.2% below this industry median. Based on the distribution chart, Ayurcann Holdings ranks #323 out of 919 companies in the Drug Manufacturers industry, which is above the industry midpoint.
How does Ayurcann Holdings' Days Payable compare to BSPK and SKYI?
According to the Drug Manufacturers industry distribution chart, Ayurcann Holdings ranks #323 out of 919 companies for Days Payable. This puts Ayurcann Holdings in the upper half of its industry. The industry median Days Payable is 90.69. Ayurcann Holdings' value of 52.40 is 42.2% below this benchmark. Historically, Ayurcann Holdings' own Days Payable has ranged from 48.62 to 120.90 over the past decade. While the company's 10-year median is 65.28 vs. the industry median of 90.69, Ayurcann Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.69, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ayurcann Holdings's current Days Payable of 52.40 is 42.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Ayurcann Holdings and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ayurcann Holdings's current Days Payable is 52.40, which is 20% below median its own 10-year median of 65.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ayurcann Holdings stock overvalued right now?
Ayurcann Holdings (AYURF) has a current Days Payable of 52.40. The stock's GF Value™ is $0.01, compared to a current price of $0.00 — trading 79% below its estimated fair value. The current Days Payable is 52.40, which is 20% below median its 10-year median of 65.28 and 42.2% below the Drug Manufacturers industry median of 90.69. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Ayurcann Holdings (AYURF), the current Days Payable is 52.40 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ayurcann Holdings Corp is engaged in providing post-harvest outsourcing solutions to licensed cannabis producers and the manufacture and distribution of cannabis products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AYURF has been successfully added to your 